微卫星不稳定性高胆小板癌的成功治疗:一个病例报告
Yuichi Sakamori1, Kentaro Hamada1, Hiroaki Kawachi1
1Department of Respiratory Medicine, Japan Red Cross Society Wakayama Medical Center, 4-20 Komatsubara-dori, Wakayama City, 640-8558, Japan.
Respiratory medicine case reports
|August 5, 2025
概括
微卫星不稳定性高胸膜癌,虽然罕见,但可能对pembrolizumab有反应. 这一病例显示了显著的瘤缩,突出显示了MSI测试对免疫治疗候选人的重要性.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 胸膜癌是一种罕见的,激进的癌症.
- 转移病例通常接受缓和化疗.
- 微卫星不稳定性高 (MSI高) 瘤可能会对免疫检查点抑制剂如 pembrolizumab.
相关概念视频
01:27Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K